Answers are grounded in this paper and cite their sources.
Loss of ovarian reserve reflects both follicle depletion and deterioration of the cellular environment that supports follicular development. Whether reinforcing trophic signaling can protect this environment, and which transcriptional responses mediate such protection, remain incompletely defined. Here, we integrated human oocyte transcriptomes and clinical specimens with mouse models of cisplatin-induced ovarian injury and natural aging to investigate 7,8-dihydroxyflavone (7,8-DHF). Aged human oocytes showed reduced expression of BDNF-TrkB pathway components, while follicular-fluid BDNF was lower in women with diminished ovarian reserve and positively correlated with serum anti-Müllerian hormone. In cisplatin-treated mice, 7,8-DHF preserved primordial and developing follicles, increased serum anti-Müllerian hormone and improved litter size. Treatment also improved follicular profiles in aged mice. In KGN granulosa-like cells, 7,8-DHF reduced cisplatin-induced apoptosis, reactive oxygen species accumulation and mitochondrial depolarization. Integrative transcriptomic analysis identified FOS and SOCS3 as candidate mediators. The TrkB antagonist ANA-12 blocked SOCS3 induction, whereas FOS associated with the SOCS3 promoter and increased its reporter activity. FOS and SOCS3 silencing further implicated this transcriptional response in the regulation of granulosa-cell functional markers. These results link the ovarian-protective effects of 7,8-DHF to trophic signaling and FOS-SOCS3 regulation, identifying support of granulosa-cell function as a strategy for preserving the follicular reserve.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: